REFERENCES 1. Smith PW, Watkins K, Hewlett A. Infection control through the ages. Am J Infect Control. 2012;40(1):35‐42 https://doi.org/10.1016/j.ajic.2011.02.019. 2. Kernahan PJ. Causation and cleanliness: George Callender, wounds, and the debates over Listerism. J Hist Med Allied Sci. 2009;64(1):1‐37 https://doi.org/10.1093/jhmas/jrn043. 3. Vogel MJ. The invention of the modern hospital, Boston 1870‐1930. Chicago: Chicago: University of Chicago Press; 1980. 4. Durand GA, Raoult D, Dubourg G. Antibiotic discovery: history, methods and perspectives. Int J Antimicrob Agents. 2019;53(4):371‐82 https://doi.org/10.1016/j.ijantimicag.2018.11.010. 5. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985;121(2):182‐205 https://doi.org/10.1093/oxfordjournals.aje.a113990. 6. Koeleman JGM, Verbrugh HA. Preventie en bestrijding van ziekenhuisinfecties: wetten, richtlijnen en organisatie. Nederlands Tijdschrift voor Medische Microbiologie. 1999;7(4):115‐21. 7. Emori TG, Culver DH, Horan TC, Jarvis WR, White JW, Olson DR, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control. 1991;19(1):19‐35 https://doi.org/10.1016/0196‐6553(91)90157‐8. 8. PREZIES (Dutch national surveillance network for healthcare associated infections). History of PREZIES [Available from: https://www.rivm.nl/prezies/over‐prezies/historie‐prezies. 9. Hopmans TEM, Smid EA, Wille JC, van der Kooi TII, Koek MBG, Vos MC, et al. Trends in prevalence of healthcare‐associated infections and antimicrobial use in hospitals in the Netherlands: 10 years of national point‐prevalence surveys. J Hosp Infect. 2019 https://doi.org/10.1016/j.jhin.2019.10.005. 10. Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T, et al. Burden of Six Healthcare‐Associated Infections on European Population Health: Estimating Incidence‐Based Disability‐Adjusted Life Years through a Population Prevalence‐Based Modelling Study. PLoS Med. 2016;13(10):e1002150 https://doi.org/10.1371/journal.pmed.1002150. 11. PREZIES (Dutch national surveillance network for healthcare associated infections). Reference figures 2017 ‐ 2021: HAI prevalence surveys Bilthoven: National Institute for Public Health and the Environment (RIVM); 2023 [Available from: https://www.rivm.nl/documenten/referentiecijfers‐prezies‐prevalentieonderzoek‐2021. 12. Kadri SS, Lai YL, Warner S, Strich JR, Babiker A, Ricotta EE, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in‐vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. The Lancet infectious diseases. 2021;21(2):241‐51 https://doi.org/10.1016/S1473‐3099(20)30477‐1. 13. Bergmans DCJJ, Bonten, M.J.M.,. Nosocomial pneumonia. In: Mayhall CG, editor. Hospital epidemiology and infection control. Philadelphia: Lippincott, Williams and Wilkins; 2004. 14. Melsen WG, Rovers MM, Groenwold RH, Bergmans DC, Camus C, Bauer TT, et al. Attributable mortality of ventilator‐associated pneumonia: a meta‐analysis of individual patient data from randomised prevention studies. The Lancet infectious diseases. 2013;13(8):665‐71 https://doi.org/10.1016/S1473‐3099(13)70081‐1. 15. Rupp ME. Nosocomial bloodstream infections. In: Mayhall CG, editor. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams & Wilkins; 2004. 1 15 Introduction
RkJQdWJsaXNoZXIy MTk4NDMw